English Editing Researcher Services
Innovative Evidence Solutions
Situation & evidence gap analyses|Product positioning and strategy|Publication planning|RWE Database studies|Systematic literature reviews|Congress posters & slidekits
Strategic evidence generation planning
 

Edanz can support your needs for strategic planning and scientific messaging through:

  • Evidence mapping and analysis
  • Situation and evidence gap analysis
  • Unmet clinical needs
  • Medical and scientific positioning
  • Competitor product SWOTs
  • Publication plans & innovative ideas for evidence generation
  • RWE/database studies & meta analyses
Content development
 

Executing on a publication plan, or an individual project, we develop high-quality manuscripts and congress materials:

  • Original articles (at all stages of drug development)
  • Reviews
  • Systematic reviews & Meta analyses
  • Advisory board reports
  • Congress posters & slide-kits, congress reports
  • PLSs, visual summaries, infographics
Selected peer reviewed publications
 
About Edanz Pharma
 

Edanz Pharma provides high-quality strategic planning and evidence generation services. Edanz was founded in Japan in 1995, and joined M3 Group (Tokyo Stock Exchange First Section -securities code 2413) in 2019.

We have a team of international experts with deep academic and industry experience.

*Since April 2021, the Edanz’s medical communications business is known as “Edanz Pharma”.

Edanz Pharma leadership team
 
Ken Sakamoto
MSL
Mayako Ikeda
Senior Solutions Manager
Koji Yamashita
CEO
Tom da Costa
Chief Commercial Officer
Daniel McGowan, PhD
Chief Science Officer
  Contact us
Rigorous ethical standards
 

Edanz strictly adheres to international guidelines regarding medical writing best practice, including GPP3, ISMPP, EMWA, ICMJE guidelines.

 
© Edanz 2021